XL Neph 5 Tablet ER contains Prazosin 5 mg, an alpha-1 adrenergic receptor antagonist primarily indicated for the management of hypertension and symptoms of benign prostatic hyperplasia (BPH). By selectively blocking alpha-1 receptors on vascular smooth muscle, Prazosin induces vasodilation, resulting in decreased peripheral vascular resistance and lowered blood pressure. The extended-release formulation ensures a gradual and sustained release of the active ingredient, promoting stable plasma concentrations and improved patient compliance through once-daily dosing. XL Neph 5 Tablet ER is particularly beneficial in patients requiring consistent blood pressure control without significant fluctuations. Additionally, Prazosin alleviates urinary obstruction symptoms in BPH by relaxing smooth muscle in the bladder neck and prostate, enhancing urine flow. Common adverse effects may include dizziness, headache, fatigue, and orthostatic hypotension, especially during initial therapy, warranting cautious dose titration. It is contraindicated in patients with hypersensitivity to Prazosin and should be used with caution in those with hepatic impairment or a history of syncope. Concomitant use with other antihypertensive agents may potentiate hypotensive effects. Regular monitoring of blood pressure and clinical response is recommended to optimize therapeutic outcomes. XL Neph 5 Tablet ER offers an effective and well-tolerated option for managing hypertension and BPH-related symptoms.